Vaccinex Inc (VCNX) Annual Balance Sheets

Annual · GAAP · USD millions
Access VCNX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Vaccinex Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent1.11
Cash & Short-term Investments1.00
Accounts receivable0.84
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.59
Total Current Assets2.53
Equipment/Property/Plant Net0.07
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets2.60
Liabilities
Accounts Payable, Current AC3.96
Accrued Liabilities, Current AC1.10
Derivative Liability, Current DE0.00
Long-term Debt, Current Maturities LO0.03
Other Liabilities, Current0.00
Total Current Liabilities5.08
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Total Liabilities5.08
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock354.42
Retained Earnings / Accumulated Deficit-358.56
Other Equity0.00
Common Stockholder's Equity-4.15
Preferred Stockholder's Equity1.67
Non-controlling interests & other0.00
Total Stockholder's Equity-2.49
Liabilities & Stockholder's Equity2.60
4 historic quarters locked

Sign in to unlock the full Vaccinex Inc balance sheet history.

About Vaccinex Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-054318

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.